Biohaven BHVN Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Returns | |||||
| Return on equity | -310.8%-112pp | -198.8%-114pp | -84.4%+114pp | -198.9%+632pp | |
| Return on assets | -138.5%+11.5pp | -150%-80.6pp | -69.5%+72.4pp | -141.9%— | |
| Return on invested capital | -323.1%-9.4pp | -313.8%-151pp | -162.6%— | —— | |
| Liquidity | |||||
| Current ratio | 3.2×-0.3× | 3.5×-4.5× | 8×+1.5× | 6.5×+4.3× | |
| Quick ratio | 3.2×-0.3× | 3.5×-4.5× | 8×+1.5× | 6.5×+4.3× | |
| Cash ratio | 2×+1.3× | 0.7×-3.9× | 4.5×+1.9× | 2.7×+0.9× | |
| Leverage | |||||
| Debt-to-equity | 5.5×+5.4× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0.6×+0.6× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Per Share | |||||
| Book value per share | $0.48-89.6% | $4.64-22.8% | $6.01-50.1% | $12.04+1,267% | |
| Valuation | |||||
| Market capitalization | $1.5B-60.3% | $3.78B+10.0% | $3.43B+263% | $946.07M— | |
| Enterprise value | $1.55B-58.2% | $3.71B+15.5% | $3.21B+336% | $737.07M— | |
| Price / book | 28.8×+19.8× | 8.9×+0.9× | 8×+6.3× | 1.8×— | |
| Free cash flow yield | -40.7%-25.2pp | -15.5%-5.8pp | -9.7%+22.4pp | -32.1%— | |
| Earnings yield | -49.3%-26.9pp | -22.4%-10.5pp | -11.9%+48.4pp | -60.3%— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Biohaven's ratios come from?
- Every ratio is computed from Biohaven's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.